Congo vs Trinidad and Tobago: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Congo
27.0%
in 2014
Trinidad and Tobago
24.0%
in 2014
Congo rank
89th
Trinidad and Tobago rank
90th
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Congo
- Trinidad and Tobago
How they compare
Congo currently reports 27.0% against 24.0% in Trinidad and Tobago, a difference of 3.0%.
That makes Congo's figure about 1.1 times Trinidad and Tobago's.
The two have swapped places 2 times across 8 shared years of data; in 2007 it was Congo ahead.
Congo ranks 89th and Trinidad and Tobago ranks 90th of 104 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Congo | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.3% | 14.0% | 53.3% | Congo |
| 2010s | 17.6% | 22.2% | 4.6% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Congo or Trinidad and Tobago?
- Congo, at 27.0% against 24.0% in Trinidad and Tobago as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Congo and Trinidad and Tobago?
- 3.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Trinidad and Tobago?
- 8 years are reported by both, from 2007 to 2014.
- How do Congo and Trinidad and Tobago rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Congo ranks 89th and Trinidad and Tobago ranks 90th of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.